| Image processing and analysis methods for the Adolescent Brain Cognitive Development Study DJ Hagler Jr, SN Hatton, MD Cornejo, C Makowski, DA Fair, AS Dick, ... Neuroimage 202, 116091, 2019 | 910 | 2019 |
| Development of a definition of postacute sequelae of SARS-CoV-2 infection T Thaweethai, SE Jolley, EW Karlson, EB Levitan, B Levy, GA McComsey, ... Jama 329 (22), 1934-1946, 2023 | 597 | 2023 |
| Research Review: What have we learned about adolescent substance use? KM Gray, LM Squeglia Journal of child psychology and psychiatry 59 (6), 618-627, 2018 | 409 | 2018 |
| A Double-Blind Randomized Controlled Trial of N-Acetylcysteine in Cannabis-Dependent Adolescents KM Gray, MJ Carpenter, NL Baker, SM DeSantis, E Kryway, KJ Hartwell, ... American Journal of Psychiatry 169 (8), 805-812, 2012 | 376 | 2012 |
| Alcohol and drug use and the developing brain LM Squeglia, KM Gray Current psychiatry reports 18, 1-10, 2016 | 304 | 2016 |
| Unconscious bias and the diagnosis of disruptive behavior disorders and ADHD in African American and Hispanic youth MC Fadus, KR Ginsburg, K Sobowale, CA Halliday-Boykins, BE Bryant, ... Academic Psychiatry 44, 95-102, 2020 | 274 | 2020 |
| Oral cannabidiol does not alter the subjective, reinforcing or cardiovascular effects of smoked cannabis M Haney, RJ Malcolm, S Babalonis, PA Nuzzo, ZD Cooper, G Bedi, ... Neuropsychopharmacology 41 (8), 1974-1982, 2016 | 227 | 2016 |
| Determining menstrual phase in human biobehavioral research: A review with recommendations. AM Allen, AL McRae-Clark, S Carlson, ME Saladin, KM Gray, ... Experimental and clinical psychopharmacology 24 (1), 1, 2016 | 205 | 2016 |
| Potential Role of N-Acetylcysteine in the Management of Substance Use Disorders EA McClure, CD Gipson, RJ Malcolm, PW Kalivas, KM Gray CNS drugs 28, 95-106, 2014 | 178 | 2014 |
| Reductions in cannabis use are associated with improvements in anxiety, depression, and sleep quality, but not quality of life YI Hser, LJ Mooney, D Huang, Y Zhu, RL Tomko, E McClure, CP Chou, ... Journal of substance abuse treatment 81, 53-58, 2017 | 157 | 2017 |
| A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults KM Gray, SC Sonne, EA McClure, UE Ghitza, AG Matthews, ... Drug and alcohol dependence 177, 249-257, 2017 | 153 | 2017 |
| N-acetylcysteine (NAC) in young marijuana users: an open-label pilot study KM Gray, NL Watson, MJ Carpenter, SD LaRowe The American journal on addictions/American Academy of Psychiatrists in …, 2010 | 150 | 2010 |
| Cigarette warning label policy alternatives and smoking-related health disparities JF Thrasher, MJ Carpenter, JO Andrews, KM Gray, AJ Alberg, A Navarro, ... American journal of preventive medicine 43 (6), 590-600, 2012 | 145 | 2012 |
| Nicotine therapy sampling to induce quit attempts among smokers unmotivated to quit: a randomized clinical trial MJ Carpenter, JR Hughes, KM Gray, AE Wahlquist, ME Saladin, ... Archives of internal medicine 171 (21), 1901-1907, 2011 | 140 | 2011 |
| Gender differences in craving and cue reactivity to smoking and negative affect/stress cues ME Saladin, KM Gray, MJ Carpenter, SD LaRowe, SM DeSantis, ... The American journal on addictions 21 (3), 210-220, 2012 | 138 | 2012 |
| Current, future and potential use of mobile and wearable technologies and social media data in the ABCD study to increase understanding of contributors to child health KS Bagot, SA Matthews, M Mason, LM Squeglia, J Fowler, K Gray, ... Developmental cognitive neuroscience 32, 121-129, 2018 | 129 | 2018 |
| Systematic and meta-analytic review of research examining the impact of menstrual cycle phase and ovarian hormones on smoking and cessation AH Weinberger, PH Smith, SS Allen, KP Cosgrove, ME Saladin, KM Gray, ... Nicotine & Tobacco Research 17 (4), 407-421, 2015 | 116 | 2015 |
| A double blind, placebo-controlled study of the effects of post-retrieval propranolol on reconsolidation of memory for craving and cue reactivity in cocaine dependent humans ME Saladin, KM Gray, AL McRae-Clark, SD LaRowe, SD Yeatts, ... Psychopharmacology 226, 721-737, 2013 | 115 | 2013 |
| Cognitive enhancers in the treatment of substance use disorders: clinical evidence KT Brady, KM Gray, BK Tolliver Pharmacology Biochemistry and Behavior 99 (2), 285-294, 2011 | 112 | 2011 |
| Adolescent substance use disorder treatment: an update on evidence-based strategies MC Fadus, LM Squeglia, EA Valadez, RL Tomko, BE Bryant, KM Gray Current psychiatry reports 21, 1-10, 2019 | 110 | 2019 |
